News | Brachytherapy Systems, Women's Healthcare | April 20, 2017

New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting

Research examines role of electronic brachytherapy system in various intraoperative radiotherapy applications

New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting

April 20, 2017 — iCAD Inc. announced that updated clinical data on the use of intraoperative radiation therapy (IORT) using the Xoft Axxent Electronic Brachytherapy (eBx) System will be presented during the American Brachytherapy Society (ABS) Annual Meeting, April 21-22 in Boston. The Xoft System and its suite of products will also be showcased at the Xoft booth.

At the meeting, Gary Proulx, M.D., medical director, radiation oncology at Exeter Hospital (N.H.) will present updated findings on his recent clinical experience treating 94 early-stage breast cancer patients with IORT using the Xoft System. The snap oral presentation is entitled “Intraoperative Radiation (IORT) as Adjuvant Radiation Monotherapy for Early-Stage Breast Cancer Patients Treated with Breast Conserving Surgery.”

“Early results from our research suggest that this short course of full-dose radiation in a single treatment offers a low rate of local failure and a high rate of excellent cosmesis for properly selected patients. We are happy to report that 100 percent of patients were very pleased with the treatment experience and treatment outcome on follow up visits,” said Proulx. “I am very encouraged by the early results of our research that indicate improved quality of life for patients eligible for IORT by greatly reducing the number of treatments patients receive when compared to EBRT.”

In addition, Ajay Bhatnagar, M.D., MBA, radiation oncologist at 21st Century Oncology (Ariz.), will participate in a panel discussion and several workshops during the meeting to review his recent clinical experience in treating nonmelanoma skin cancer (NMSC) with the Xoft System. 

The Xoft System is an isotope-free radiation treatment that is FDA cleared, CE marked, and licensed in a growing number of countries for the treatment of cancer anywhere in the body, including treatment of early-stage breast cancer, gynecological cancers and non-melanoma skin cancer. It utilizes a proprietary miniaturized X-ray as the radiation source that delivers precise treatment directly to cancerous areas while sparing healthy tissue and organs. The system requires only minimal shielding and therefore does not require room redesign or construction investment. Minimal shielding also allows medical personnel to remain in the room with the patient during treatment. The mobility of the Xoft System makes it easy to treat patients at multiple locations and to easily store the system when not in use.

For more information: www.xoftinc.com

Related Content

California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Overlay Init